HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- Novel approaches to malignant brain tumor treatment aim to overcome familiar challenges Jennifer R. Southall
-
- Should brachytherapy play a key role in the treatment of adult malignant brain tumors?
- APP understanding of hepatic arterial infusion pump function crucial for treatment success Lisa Parks, MS, APRN-CNP, ANP-BC
- Music: The universal language Nicholas J. Petrelli, MD, FACS
- Regimen extends survival in prostate cancer subset Devin McLaughlin
- Breast cancer overdiagnoses in U.S. common, inaccurately reported Jennifer R. Southall
- Clonal hematopoiesis ‘surprisingly’ linked to lower risk for Alzheimer’s disease Devin McLaughlin
- Conversations about goals of care often occur too late in high-risk AML Mark Leiser
- COVID-19 vaccination may be less effective for patients with multiple myeloma Ryan Lawrence
-
- Agent active in previously treated ovarian cancer Mark Leiser
- Most patients with AML, myelodysplastic syndrome seropositive after two doses of COVID vaccine Ryan Lawrence
- Combination extends EFS in resectable NSCLC Mark Leiser
- Precision medicine interpreted with ‘right tools’ beneficial in metastatic breast cancer Mark Leiser
- Vaccine designed to prevent triple-negative breast cancer undergoes phase 1 trial Jennifer Byrne
- Breast cancer researchers to be honored at symposium
- Melanoma specialist named ASCO’s 2023-2024 president
- Roswell Park appoints chair in gynecologic oncology
-
- UCSF appoints neuro-oncology division chief